PReS-FINAL-2112: Mapping the treatment effect of infliximab on a case of refractory anterior uveitis related to juvenile idiopathic arthritis (JIA)

被引：0
|
作者：
V Miranda
C Zilhão
P Menéres
M Guedes
机构：
[1] Hospital de Santo Antonio,Ophthalmology
[2] Hospital de Santo Antonio,Pediatrics
来源：
Pediatric Rheumatology | / 11卷 / Suppl 2期
关键词：
Infliximab; Juvenile Idiopathic Arthritis; Uveitis; Well Correct Visual Acuity; Anterior Uveitis;
D O I：
10.1186/1546-0096-11-S2-P124
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Treating juvenile idiopathic arthritis (JIA)-related uveitis beyond TNF-α inhibition: a narrative review
    Carla Gaggiano
    Donato Rigante
    Gian Marco Tosi
    Antonio Vitale
    Bruno Frediani
    Salvatore Grosso
    Claudia Fabiani
    Luca Cantarini
    [J]. Clinical Rheumatology, 2020, 39 : 327 - 337
  • [32] Treating juvenile idiopathic arthritis (JIA)-related uveitis beyond TNF-α inhibition: a narrative review
    Gaggiano, Carla
    Rigante, Donato
    Tosi, Gian Marco
    Vitale, Antonio
    Frediani, Bruno
    Grosso, Salvatore
    Fabiani, Claudia
    Cantarini, Luca
    [J]. CLINICAL RHEUMATOLOGY, 2020, 39 (02) : 327 - 337
  • [33] Long-term evaluation of efficacy and safety of infliximab in the treatment of persistently active juvenile idiopathic arthritis (JIA), refractory to standard treatments
    Gerloni, V
    Pontikaki, I
    De Marco, G
    Valcamonica, E
    Gattinara, M
    Teruzzi, B
    Lurati, A
    Salmaso, A
    Fantini, F
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 : 515 - 515
  • [34] PReS-FINAL-2142: Predictors of persistent remission following etanercept (ETN) withdrawal in patients with juvenile idiopathic arthritis (JIA)
    F Perfetti
    F Gesualdo
    V Messia
    A Insalaco
    C Bracaglia
    M Pardeo
    R Nicolai
    L Meli
    F De Benedetti
    S Magni Manzoni
    [J]. Pediatric Rheumatology, 11 (Suppl 2)
  • [35] Efficacy of adalimumab in refractory juvenile idiopathic arthritis related uveitis: report of 6 cases
    O Vougiouka
    E Atsali
    C Panousi-Vlahou
    S Azaris
    A Koidou
    [J]. Pediatric Rheumatology, 9 (Suppl 1)
  • [36] PReS-FINAL-2138: Abatacept (orencia) in treatment of different types of juvenile idiopathic arthritis
    ES Zholobova
    OU Konopelko
    LA Galstyan
    OS Rozvadovskaya
    MN Nikolaeva
    [J]. Pediatric Rheumatology, 11 (Suppl 2)
  • [37] EFFICACY AND SAFETY OF ADALIMUMAB TREATMENT FOR REFRACTORY JUVENILE IDIOPATHIC ARTHRITIS-ASSOCIATED UVEITIS
    Alekseeva, E.
    Mitenko, E.
    Bzarova, T. M.
    Valiyeva, S. I.
    Isayeva, K. B.
    Chomakhidze, A. M.
    Denisova, R. V.
    Sleptsova, T. V.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2013, 71 : 514 - 514
  • [38] Infliximab or etanercept in the treatment of children with refractory juvenile idiopathic arthritis:: an open label study
    Lahdenne, P
    Vähäsalo, P
    Honkanen, V
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2003, 62 (03) : 245 - 247
  • [39] Abatacept for refractory juvenile idiopathic arthritis-associated uveitis: two case reports
    Elhai, M.
    Monnet, D.
    Job-Deslandre, C.
    [J]. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2011, 29 (02) : 421 - 421
  • [40] Long-term evaluation (efficacy and safety) of infliximab in the treatment of persistently active juvenile idiopathic arthritis (JIA), refractory to standard treatments.
    Gerloni, V
    Pontikaki, I
    De Marco, G
    Gattinara, M
    Valcamonica, E
    Lurati, A
    Salmaso, A
    Teruzzi, B
    Fantini, F
    [J]. ARTHRITIS AND RHEUMATISM, 2005, 52 (09): : S84 - S84
12345